Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Large granular lymphocytic leukemia: an overview

T P Loughran1

  • 1H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.

Hospital Practice (1995)
|June 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogenesis of Autoimmune Diseases in Large Granular Lymphocyte Leukemia.

Hematology (Amsterdam, Netherlands)·2016
Same author

Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.

Leukemia·2015
Same author

Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998).

Leukemia·2014
Same author

HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains.

Oncogene·2013
Same author

Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation.

Blood cancer journal·2013
Same author

Cyclophosphamide as a first-line therapy in LGL leukemia.

Leukemia·2013

Large granular lymphocyte leukemia involves distinct T-cell and natural killer cell types. T-large granular lymphocytic leukemia is linked to autoimmune conditions like rheumatoid arthritis.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Large granular lymphocytes (LGLs) are cytotoxic lymphocytes with Natural Killer (NK) and T-cell phenotypes.
  • Neoplastic proliferation of LGLs can lead to distinct leukemias, suggesting varied underlying etiologies.
  • T-cell LGL leukemia is frequently associated with autoimmune disorders, notably rheumatoid arthritis.

Purpose of the Study:

  • To elucidate the distinct characteristics and clinical implications of T-cell large granular lymphocytic leukemia.
  • To explore the association between T-cell LGL leukemia and autoimmune phenomena.

Main Methods:

  • Review of clinical data and laboratory findings in patients with T-cell LGL leukemia.
  • Analysis of the prevalence and types of autoimmune features observed.

Related Experiment Videos

  • Correlation of autoimmune associations with disease presentation and prognosis.

    • Main Results:

    • T-cell LGL leukemia exhibits significant autoimmune manifestations.
    • Rheumatoid arthritis is a particularly common co-occurring autoimmune disease.
    • The presence of autoimmune features influences the clinical course of T-cell LGL leukemia.

    Conclusions:

    • T-cell LGL leukemia is a distinct entity with a strong predilection for autoimmune associations.
    • Recognition of these autoimmune features is crucial for comprehensive patient management.
    • Further research into the pathogenetic links between T-cell LGL leukemia and autoimmunity is warranted.